Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina M Mueller

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|June 11, 2013
Reply: To PMID 21725989Kristina M Mueller, Richard Moriggl
Molecular and Cellular Endocrinology|May 9, 2012
Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer developmentKristina M Mueller, Madeleine Themanns, Katrin Friedbichler, et al.
Cytokine|November 1, 2018
STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in miceDoris Kaltenecker, Madeleine Themanns, Kristina M Mueller, et al.
Plos One|July 12, 2014
Reliable quantification of protein expression and cellular localization in histological sectionsMichaela Schlederer, Kristina M Mueller, Johannes Haybaeck, et al.
Translational Oncology|May 1, 2015
Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 ActivationAlexander Schütz, Katrin Röser, Jana Klitzsch, et al.
Diabetologia|November 19, 2016
Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in miceDoris Kaltenecker, Kristina M Mueller, Pia Benedikt, et al.
Molecular Metabolism|May 31, 2020
STAT5 is required for lipid breakdown and beta-adrenergic responsiveness of brown adipose tissueDoris Kaltenecker, Katrin Spirk, Frank Ruge, et al.
Cytokine|November 4, 2018
Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progressionDoris Kaltenecker, Madeleine Themanns, Kristina M Mueller, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancerKatrin Friedbichler, Madeleine Themanns, Kristina M Mueller, et al.
Oncotarget|October 14, 2015
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse modelTsion Zewdu Minas, Jenny Han, Tahereh Javaheri, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|June 11, 2013
Reply: To PMID 21725989Kristina M Mueller, Richard Moriggl
Molecular and Cellular Endocrinology|May 9, 2012
Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer developmentKristina M Mueller, Madeleine Themanns, Katrin Friedbichler, et al.
Cytokine|November 1, 2018
STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in miceDoris Kaltenecker, Madeleine Themanns, Kristina M Mueller, et al.
Plos One|July 12, 2014
Reliable quantification of protein expression and cellular localization in histological sectionsMichaela Schlederer, Kristina M Mueller, Johannes Haybaeck, et al.
Translational Oncology|May 1, 2015
Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 ActivationAlexander Schütz, Katrin Röser, Jana Klitzsch, et al.
Diabetologia|November 19, 2016
Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in miceDoris Kaltenecker, Kristina M Mueller, Pia Benedikt, et al.
Molecular Metabolism|May 31, 2020
STAT5 is required for lipid breakdown and beta-adrenergic responsiveness of brown adipose tissueDoris Kaltenecker, Katrin Spirk, Frank Ruge, et al.
Cytokine|November 4, 2018
Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progressionDoris Kaltenecker, Madeleine Themanns, Kristina M Mueller, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancerKatrin Friedbichler, Madeleine Themanns, Kristina M Mueller, et al.
Oncotarget|October 14, 2015
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse modelTsion Zewdu Minas, Jenny Han, Tahereh Javaheri, et al.
Pageof 2